In Vitro Fertilization (IVF) Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028
See less
In Vitro Fertilization (IVF) Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028
The In Vitro Fertilization (IVF) Market is segmented by Reagent Type (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, and OVUM Processing Media),by Equipment Type (Imaging Systems, Sperm Separation Systems, Cabinets, OVUM Aspiration Pumps, Incubators, Micromanipulator Systems, Gas Analyzers and Others),by Cycle Type (Fresh Non-Donor IVF Cycles, Frozen Non-Donor IVF Cycles, Frozen Donor IVF Cycles, and Fresh Donor IVF Cycles), by End-User Type (Fertility Clinics & Surgical Centers, Hospitals & Research Laboratories, and Cryobanks) andby Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others])
The In Vitro Fertilization (IVF) Market is segmented by Reagent Type ...
"The In Vitro Fertilization (IVF) Market is expected to grow from USD 669.9 million in 2021 to USD 1,256.35 million by 2028 at a CAGR of over 9.29% during the forecast period of 2022-2028".
In vitro fertilization (IVF) is defined as a type of assisted reproduction in which a woman’s eggs and man’s sperm are combined outside of the body in a Petri/laboratory dish. IVF is the most widely used method for assisted reproduction due to the usage of advanced technology and favorable reimbursement policies.
Market Drivers
Technological advancement in the IVF-assisted reproduction method is a prominent trend noticed in the global market.
The growth of the global IVF market is primarily driven by declining fertility rates owing to various factors such as stress, pollution, an increase in people smoking, and obesity.
Increasing awareness among people regarding infertility and the availability of various methods to treat infertility problems is likely to create lucrative opportunities for the players operating in the global IVF Market during the review period.
COVID-19 Impact
The market growth was affected when governments across geographies imposed lockdowns which resulted in travel restrictions. Also, many non-essential medical and surgical procedures including IVF were put to a halt which affected the market growth.
Various patients agreed to cancel fertility cycles due to fear of infection which further affected the market growth. However, patients are likely to resume IVF treatment with a decline in COVID-19 cases and the availability of vaccines.
Segments Analysis
Segmentations
List of Sub-Segments
Dominant and Fastest-Growing Segments
End-User-Type Analysis
Fertility Clinics & Surgical Centers, Hospitals & Research Laboratories, Cryobanks
The Fertility Clinics & Surgical Centers segment held the largest share of the market.
Reagent-Type Analysis
Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, and OVUM Processing Media
The Embryo Culture Media segment held the largest market share.
The Frozen Non-Donor IVF Cycles segment held the largest market share.
Regional Analysis
North America, Europe, Asia-Pacific, and Rest of the World
Europe held the largest market share, while Asia-Pacific is expected to grow the fastest during the forecast period.
By End-User Type
“The Fertility Clinics & Surgical Centers segment held the largest share of the market”.
The market has been segmented into fertility clinics & surgical centers, hospitals & research laboratories, and cryobanks. The segment growth can be attributed to the increasing number of fertility clinic centers coupled with rising infertility rates globally. The Fertility Clinics & Surgical Centers segment accounted for thelargest market share of more than 75% in 2021.
By Reagent Type
“The Embryo Culture Media segment held the largest market share”.
The market has been segmented into embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. The expansion was ascribed to factors such as increased research efforts to improve media for culture and more accessible funding. The Embryo Culture Media segment accounted for the largest market share of more than 40% in 2021.
By CycleType
“The Frozen Non-Donor IVF Cycles segment held the largest market share”.
The market has been segmented into fresh non-donor IVF cycles, frozen non-donor IVF cycles, frozen donor IVF cycles, and fresh donor IVF cycles. The Frozen Non-Donor IVF Cycles segment accounted for the largest market share of more than 45% in 2021. The segment is expected to register the fastest growth over the forecast period. The high percentage can be attributed to the cost-effectiveness when compared to fresh non-donor sperm, as well as the procedure's less-invasive nature.
Regional Analysis
“Europe held the largest market share, while Asia-Pacific is expected to grow the fastest during the forecast period”.
The market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The market in Europe accounted for the largest market share of more than 35% in 2021 owing to increasing infertility rates; rising awareness, and continuous spending on R&D activities to develop technologically advanced solutions for health problems. The market in Asia-Pacific is expected to register the fastest growth during the forecast period on account of the growing median age of first-time motherhood, rising infertility rates, and low treatment costs.
Want to know which region offers the best growth opportunities?Register Here
Key Players
The following are the key players in the In Vitro Fertilization (IVF) Market (arranged alphabetically)
Cook Medical Incorporated (The U.S.)
Cooper Surgical Inc. (The U.S.)
EMD Serono (The U.S.)
Esco Micro Pte Ltd (Singapore)
Genea Limited (Australia)
IVF Tech APS (Denmark)
Irvine Scientific (The U.S.)
Kitazato Corporation (Japan)
Rocket Medical (UK)
The Baker Company, Inc. (The U.S.)
Thermo Fisher Scientific (The U.S.)
Vitro Life (Sweden)
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
in-depth Analysis of the In Vitro Fertilization (IVF) Market
How lucrative is the future?
The market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional, and country-level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and Forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.
We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research:
Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
In vitro fertilization is defined as a type of assisted reproduction in which a women’s eggs and man’s sperm are combined outside of the body in a Petri/laboratory dish. In vitro fertilization is the most widely used method for assisted reproduction due to the usage of advanced technology and favorable reimbursement policies.
Technological advancements in IVF-assisted reproduction methods are a significant trend in the global market. The growth of the global IVF market is primarily driven by declining fertility rates, which can be attributed to factors such as stress, pollution, increased smoking rates, and obesity. Growing awareness about infertility and the availability of various treatment options are expected to create lucrative opportunities for players in the global In Vitro Fertilization market during the review period.
The key players operating in the IVF Market are-Cooper Surgical Inc. (The U.S.), Vitro Life (Sweden), Cook Medical Incorporated (The U.S.), Thermo Fisher Scientific (The U.S.), Irvine Scientific (The U.S.), Genea Limited (Australia), The Baker Company, Inc. (The U.S.), Kitazato Corporation (Japan), Esco Micro Pte Ltd (Singapore), EMD Serono (The U.S.), IVF Tech APS (Denmark), Rocket Medical (UK).